Norstella Executive and Leadership Team

Michael Gallup, the Chief Executive Officer at Norstella, directs the overarching corporate strategy and mission to improve patient access across the global life sciences landscape. Overseeing the integration of Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group, the Chief Executive Officer ensures that all business units align with the goal of delivering critical commercial intelligence. This leadership role involves managing high-level partnerships and driving the expansion of data-driven solutions that support drug development from pipeline to patient. By fostering a culture of innovation and operational excellence, Michael Gallup maintains the company's position as a premier intelligence provider. The Chief Executive Officer also collaborates with the Board to secure long-term growth and market stability, ensuring that the organization remains at the forefront of pharmaceutical technology and predictive analytics while navigating complex regulatory environments.

Daniel Tempesta, the Chief Financial Officer at Norstella, manages the financial health and fiscal strategy of the organization to support long-term growth and operational efficiency. Overseeing capital allocation, financial planning, and reporting, the Chief Financial Officer ensures that the company maintains the resources necessary to invest in advanced data technologies and market expansion. This role involves providing the financial oversight required to integrate diverse business units into a cohesive, high-performing entity. By analyzing market performance and identifying investment opportunities, Daniel Tempesta drives the financial stability that allows the company to continue delivering essential intelligence to life sciences clients. The Chief Financial Officer also works with the executive team to align budgetary priorities with the overarching mission of improving patient access. Through disciplined financial management, Tempesta supports the company's ability to navigate the competitive landscape and achieve sustainable commercial success.

Joshua Murphy, the Chief Revenue Officer at Norstella, drives the global commercial strategy and revenue growth initiatives across the entire portfolio of intelligence solutions. Overseeing the sales organization, the Chief Revenue Officer ensures that life sciences clients receive tailored access to market-leading data assets and advisory services. This role involves architecting scalable go-to-market strategies that capitalize on the company's unique position in the pharmaceutical intelligence sector. By aligning commercial efforts with the needs of drug developers, Joshua Murphy maximizes market penetration and strengthens client relationships. The Chief Revenue Officer also works closely with other C-suite leaders to refine product positioning and enhance the value proposition of the company's integrated offerings. Through rigorous analysis of market trends and customer requirements, Murphy secures consistent financial performance and supports the broader mission of improving patient access through commercial excellence.

Andy Augustine, the Chief Technology Officer at Norstella, architects the technological infrastructure and data platforms that power the company's intelligence solutions. Overseeing the development of machine learning models and predictive analytics, the Chief Technology Officer ensures that all digital tools provide actionable insights for life sciences clients. This leadership role involves managing the integration of complex data sets across the organization to support drug development life cycles. By driving innovation in software engineering and data architecture, Andy Augustine enables the company to deliver cutting-edge solutions that address critical commercial decision-making needs. The Chief Technology Officer also collaborates with product teams to ensure that technological capabilities remain ahead of industry demands. Through the implementation of robust, scalable systems, Augustine supports the company's commitment to providing high-quality, reliable intelligence that helps clients navigate the complexities of the pharmaceutical market.

Joel Keefe, the Chief Revenue Officer, Mmit, Skipta, Panalgo, Rwd & Evidence Generation at Norstella, directs the commercial strategy specifically focused on real-world data and evidence generation services. Overseeing the revenue streams for these specialized business units, the Chief Revenue Officer ensures that clients leverage high-quality evidence to support market access and commercialization efforts. This role involves driving the adoption of real-world data solutions that help pharmaceutical companies demonstrate value and improve patient outcomes. By aligning the capabilities of MMIT, Skipta, and Panalgo, Joel Keefe creates a unified approach to evidence generation that addresses the unique needs of the life sciences industry. The Chief Revenue Officer also collaborates with cross-functional teams to expand the reach of these services across global markets. Through strategic leadership, Keefe ensures that the company remains a leader in providing the evidence-based insights required for successful drug development and commercial decision-making.

Shrinal Patel, the Chief Medical Officer at Norstella, provides the clinical expertise and medical leadership necessary to ensure the accuracy and relevance of the company's intelligence solutions. Overseeing the medical integrity of data assets, the Chief Medical Officer ensures that all insights align with current clinical standards and patient care requirements. This role involves guiding the development of intelligence products that support drug development from early-stage pipelines to patient access. By integrating medical knowledge into the company's predictive analytics and advisory services, Shrinal Patel helps clients navigate the complexities of the pharmaceutical landscape with clinical precision. The Chief Medical Officer also collaborates with other executives to ensure that the company's strategic direction remains grounded in medical reality. Through the application of deep clinical insight, Patel supports the organization's mission to improve patient access by providing the most accurate and actionable medical intelligence available.